Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways-Reference-Cited by-同舟云学术

Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways

Published:2016-05-04 Issue:24 Volume:7 Page:36767-36782
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cui Shu-Xiang¹,Shi Wen-Na²,Song Zhi-Yu²,Wang Shu-Qing²,Yu Xin-Feng²,Gao Zu-Hua³,Qu Xian-Jun²

Affiliation:

1. Beijing Key Laboratory of Environmental Toxicology, Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, China

2. Department of Pharmacology, Capital Medical University School of Basic Medical Sciences, Beijing, China

3. Department of Pathology, McGill University, Montreal, Quebec, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways;International Journal of Pharmaceutics: X;2024-12

2. Cinobufacini Inhibits Survival and Metastasis of Hepatocellular Carcinoma via c-Met Signaling Pathway;Chinese Journal of Integrative Medicine;2024-07-19

3. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of HIF-1α and ANGPT2;International Journal of Molecular Sciences;2022-01-31

4. The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach;Pharmacological Reports;2022-01-28

5. Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration;Frontiers in Immunology;2022-01-13